According to Zhituo Finance, on November 22, the "Qi Pu Award" for the Chinese health industry officially announced the TOP 10 and future stars of the 2024 Qi Pu Seed List. Shanghai jinhai med tech Co., Ltd. (02225) has made it to the "2024 Medical Instruments Innovation Qi Pu Seed List TOP 10" with its project "4K Naked Eye 3D Fluorescence Intelligent Navigation Endoscope System."

"Qi Pu Award" is a highly influential and authoritative innovation award in China’s health industry, jointly selected by top experts, scholars, and seasoned investors in the field. It aims to discover and honor enterprises and projects that excel in technological innovation, clinical value, and market potential. Award-winning projects not only represent the forefront of technology in China's health industry but are also seen as important barometers for the development of capital markets and the industry.

Jinhai med tech has been continuously deepening its research and development in endoscope technology in recent years, achieving several significant breakthroughs, covering a series of innovative products from 4K ultra-high-definition endoscope systems, 3D and naked eye 3D image processing systems to 4K fluorescence and future multi-spectral ultra-high-definition endoscope systems. In particular, the company launched the Endo Next series true 4K 3D 4MOS ultra-high-definition fluorescence endoscope system in July 2023, integrating the three core technologies of "4K+3D+Fluorescence" to provide more precise and efficient solutions for the field of minimally invasive surgery. Being awarded the "Qi Pu Seed List TOP 10" is not only a high recognition of jinhai med tech's technological innovation strength but also highlights its key role in driving industry change.